BeyondSpring Announces Positive Pre-NDA Meeting with the U.S. FDA for its Lead Asset, Plinabulin
Company On Track to Submit New Drug Applications for Non-Small Cell Lung Cancer and Chemotherapy-Induced Neutropenia in the United States […]
Company On Track to Submit New Drug Applications for Non-Small Cell Lung Cancer and Chemotherapy-Induced Neutropenia in the United States […]
TORONTO, Dec. 27, 2018 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQB: RVLGF) (“Revival Gold” or the “Company”), a […]
SALT LAKE CITY, Dec. 27, 2018 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN) announced today that Mark C. Capone, […]
RESEARCH TRIANGLE PARK, N.C., Dec. 27, 2018 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today […]
BERKELEY HEIGHTS, N.J., Dec. 27, 2018 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a [...]
FDA clearance of IND received for Phase 2 trial of AXS-12 in narcolepsy Phase 2 results of AXS-05 in major […]
BRIDGEWATER, N.J., Dec. 27, 2018 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated […]
Not for distribution to U.S. newswire services nor for dissemination to the United States. BROOKFIELD NEWS, Dec. 27, 2018 (GLOBE […]
PARSIPPANY, NJ, Dec. 27, 2018 (GLOBE NEWSWIRE) — Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that CIO Applications, a publication […]
All amounts in US dollars unless otherwise indicated BROOKFIELD, News, Dec. 27, 2018 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. […]